Move comes 2 years after controversial exit of brand-name product ...

Glenmark Specialty SA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for ...

CGT designations are granted to medicines with limited generic competition, and first‑approved applicants are eligible for ...

A popular corticosteroid inhaler used to treat asthma and other conditions is being discontinued, and despite generic versions now available, health experts are warning patients to plan ahead for ...

Glenmark Specialty SA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Fluticasone Propionate Inhalation Aerosol USP, 44 mcg per actuation.

Glenmark Pharmaceuticals announced that its subsidiary, Glenmark Specialty SA, has received final approval from the U.S. Food and Drug Administration (USFDA) for Fluticasone Propionate Inhalation ...

Starting January 1, a drug that thousands of patients depend on to help them breathe will disappear from pharmacy shelves, and doctors are concerned patients may have delays switching to alternatives ...

BRIDGEWATER, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has tentatively approved ...

WASHINGTON The Food and Drug Administration today issued a public health advisory to alert patients, caregivers and healthcare professionals to switch to hydrofluoroalkane propelled albuterol inhalers ...

People with asthma now have a new option to breathe easier. The U.S. Food and Drug Administration this week approved the first generic asthma inhaler as part of its efforts to improve access to ...